CPTR Marks Fifth Anniversary, Launches New Website
Critical Path to TB Drug Regimens (CPTR), an initiative that brings together the world’s leading pharmaceutical companies, product development sponsors,
Australia Grants Support for TB Alliance to Advance New TB Drugs
TB Alliance, a not-for-profit product development partnership with the mission of developing better, faster, and affordable drugs for tuberculosis (TB),
News
The Lancet: Results of Phase 2b Trial of Novel TB Regimen PaMZ Show Potential to Shorten, Improve TB Treatment
A new tuberculosis (TB) drug regimen designed to improve options for TB therapy eliminated more bacteria from sputum than standard
Global Phase 3 “STAND” Trial Launched to Test New Tuberculosis Drug Regimen PaMZ to Shorten, Improve Treatment
* STAND trial will take place in approximately 50 study sites in Africa, Asia, Caribbean, Eastern Europe, and Latin America
News
TB Alliance Advances Next-generation TB Drug Candidate into Clinical Testing
TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354.
News
Phase 2a Published Results Show the Potential of a New TB Regimen with Novel Drugs Bedaquiline and Pretomanid (PA-824)
A promising new tuberculosis (TB) drug regimen, which could improve the treatment of drug sensitive TB and multi-drug resistant (MDR-)
News
TB Alliance Announces Two New Members to Its Board of Directors: Dr. Mario Raviglione of WHO and Shalini Sharp of Ultragenyx
TB Alliance, an international not-for-profit organization with the mission of developing improved tuberculosis (TB) treatments, announced the appointment of Mario
News
Developing New Tuberculosis Drugs from Marine Natural Products: Joint research program between OPBIO and TB Alliance announced
OPBIO Factory Co., Ltd. (OPBIO) has signed a research agreement with the Global Alliance for TB Drug Development (TB Alliance).
News
Summary of TB Alliance & UNITAID symposium on the Pediatric TB Drug Market (full presentations available)
TB Alliance and UNITAID held a Satellite Symposium at the 45th Union World Conference on Lung Health on 31 October
News
TB Alliance Launches Phase 2B Clinical Trial of a Novel TB Drug Regimen that Could Cut Treatment Time by Half or More for a Majority of TB Patients
TB Alliance has launched a Phase 2B trial that will test the safety and effectiveness of a novel regimen with